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Lukas Schwingshackl* and Georg HoffmannAbstract
Background: Meta-analyses of short-term studies indicate favorable effects of higher protein vs. lower protein diets
on health outcomes like adiposity or cardiovascular risk factors, but their long-term effects are unknown.
Methods: Electronic databases (MEDLINE, EMBASE, Cochrane Trial Register) were searched up to August 2012 with
no restriction to language or calendar date. A random effect meta-analysis was performed using the Software
package by the Cochrane Collaboration Review Manager 5.1. Sensitivity analysis was performed for RCTs with a
Jadad Score ≥3, and excluding type 2 diabetic subjects (T2D).
Results: 15 RCTs met all objectives and were included in the present meta-analysis. No significant differences
were observed for weight, waist circumference, fat mass, blood lipids (i.e. total cholesterol, LDL-cholesterol,
HDL-cholesterol, triacylglycerols), C-reactive protein, diastolic and systolic blood pressure, fasting glucose and
glycosylated hemoglobin. In contrast, improvements of fasting insulin was significantly more pronounced
following high protein diets as compared to the low protein counterparts (weighted mean difference: -0.71 μIU/ml,
95% CI −1.36 to −0.05, p = 0.03). Sensitivity analysis of high quality RCTs confirmed the data of the primary analyses,
while exclusion of studies with diabetic subjects resulted in an additional benefit of high-protein diets with respect
to a more marked increase in HDL-cholesterol.
Conclusion: According to the present meta-analysis of long-term RCTs, high-protein diets exerted neither specific
beneficial nor detrimental effects on outcome markers of obesity, cardiovascular disease or glycemic control. Thus,
it seems premature to recommend high-protein diets in the management of overweight and obesity.
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With respect to the optimal macronutrient composition
in the daily diet, most international authorities recom-
mend to increase intakes of carbohydrates at the ex-
pense of fat and protein [1,2]. However, in face of the
worldwide increase in prevalence of both overweight
and obesity, there is a plethora of recommendations for
diets aiming at weight loss and weight management.
Among them, a high-protein (HP) regimen has gained
increasing interest in recent years [3]. For the general
population, recommended dietary reference intakes (DRIs)
for protein are 0.66 g * kg body weight-1 * d-1 [4]. Actual
consumption data for the US American population* Correspondence: lukas.schwingshackl@univie.ac.at
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Vienna, Althanstraße 14 (UZII), Vienna A-1090, Austria
© 2013 Schwingshackl and Hoffmann; license
of the Creative Commons Attribution License
distribution, and reproduction in any mediumaverage 1.3 g * kg body weight-1 * d-1 in the 19–30 age
group indicating a protein intake in excess of their needs
[5]. The Acceptable Macronutrient Distribution Range
(AMDR) for protein is given as 5-35% of daily calories de-
pending on age [6]. A recent meta-analysis comparing HP
vs. low-protein (LP) diets with a duration between 28 days
and 12 months observed favorable effects of HP diets on
biomarkers of obesity as well as cardiovascular risk factors
such as HDL-cholesterol (HDL-C), triacylglycerols (TG),
and blood pressure [7]. Several randomized controlled tri-
als (RCTs) investigated the short-term effects of HP vs. LP
diets, reporting advantages of HP protocols including a
reduction in TG concentration [8-10]. A meta-regression
of 87 studies concluded that low-carbohydrate, HP diets fa-
vorably affected body mass and composition independent
of energy intake [11]. The benefits of HP diets might bee BioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Recent data from the 26-year follow up of the Nurses’
Health Study (NHS) revealed that protein sources such as
red meat and high-fat dairy products were significantly as-
sociated with an elevated risk of coronary heart disease,
while higher intakes of poultry, fish, and nuts correlated
with a lower risk of coronary heart disease (CHD) [14].
Since there is a lack of information concerning studies with
different protein contents covering a longer dietary inter-
vention period, the aim of this meta-analysis was to com-
pare the long-term effects of HP vs. LP regimens on
biomarkers of obesity, cardiovascular complications as well
as adverse effects of HP.
Methods
The review protocol has been registered in PROS-




Literature search was performed using the electronic da-
tabases MEDLINE (between 1966 and August 2012),
EMBASE (between 1980 and August 2012), and the
Cochrane Trial Register (until August 2012) with restric-
tions to randomized controlled trials, but no restrictions
to language and calender date using the following search
term: (high protein diet). Moreover, the reference lists
from retrieved articles were checked to search for fur-
ther relevant studies. This systematic review was
planned, conducted, and reported adhearing to stan-
dards of quality for reporting meta-analyses [15]. Litera-
ture search was conducted independently by both
authors, with disagreements resolved by consensus.
Eligibility criteria
Studies were included in the meta-analysis if they met
all of the following criteria: (1) randomized controlled
design; (2) minimum intervention period with a follow-
up of 12 months; (3) comparing a HP (≥ 25% of
total energy content, TEC) with a LP dietary intervention
(≤ 20% of TEC), with both protocols adopting a low fat
diet (≤ 30% of TEC) [16]; (4) assessment of the outcome
markers: weight, waist circumference (WC), fat mass
(FM), total cholesterol (TC), low-density lipoprotein
cholesterol (LDL-C), HDL-C, TG, diastolic and systolic
blood pressure (DBP, SBP), C-reactive protein (CRP),
fasting glucose (FG), fasting insulin (FI) and glycosylated
hemoglobin (HbA1c); (5) report of post-intervention
mean values (if not available mean of two time points
were used) with standard deviation (or basic data to cal-
culate these parameters). If data of ongoing studies were
published as updates, results of only the longest duration
periods were included.Quality assessment of studies
Full copies of studies were independently assessed for
methodological quality by both authors using the Jadad
score [17]. This 5-point quality scale includes points for
randomization (randomized = 1 point; table of random
numbers or computer generated randomization = an
additional 1 point), double-blinding (double-blind = 1
point; use of a placebo = additional 1 point), and follow-
up (numbers and reasons for withdrawal in each group
are stated = 1 point) within the report of an RCT. An
additional point was accepted if the analysis was by
intention-to-treat to compensate for the fact that
double-blinded study protocols are elusive in dietary
intervention studies. Final scores of 0–2 were considered
as low quality, while final scores of ≥ 3 were regarded as
representing studies of high quality. Furthermore, the
trials were assessed for methodological quality using the
risk of bias assessment tool by the Cochrane Collabor-
ation [18] (Figure 1).
Data extraction and statistical analysis
The following data were extracted from each study: the
first author’s last name, publication year, study duration,
participant´s sex and age, BMI, % diabetics, sample size,
outcomes, drop outs and post mean values or differences
in mean of two time point values with corresponding
standard deviation. Subsequently, a standardized data ex-
traction form for this systematic review was created
according to Avenell et al. [19]. For each outcome meas-
ure of interest, a meta-analysis was performed in order to
determine the pooled effect of the intervention in terms of
weighted mean differences (WMDs) between the post-
intervention (or differences in means) values of the HP
and LP groups. Combining both the post-intervention
values and difference in means in one meta-analysis is a
legitimate method described by the Cochrane Collabor-
ation [20]. All data were analyzed using the REVIEW
MANAGER 5.1 software, provided by the Cochrane Col-
laboration (http://ims.cochrane.org/revman). Heterogen-
eity between trial results was tested with a standard χ2
test. The I2 parameter was used to quantify any inconsist-
ency: I2 = [(Q – d.f.)]/Q × 100%, where Q is the χ2 statistic
and d.f. is its degrees of freedom. A value for I2 > 50% was
considered to represent substantial heterogeneity [21]. To
consider heterogeneity, the random-effects model was
used to estimate WMDs with 95% confidence intervals
(CIs). Forest plots were generated to illustrate the study-
specific effect sizes along with a 95% CI. Funnel plots were
used to assess potential publication bias (e.g. the tendency
for studies that yield statistically significant results to be
more likely to be submitted and accepted for publication).
To determine the presence of publication bias, the sym-
metry of the funnel plots in which mean differences were
plotted against their corresponding standard errors was
Figure 1 Risk of bias assessment tool. Across trials, information is either from trials at a low risk of bias (green), or from trials at unclear risk of
bias (yellow), or from trials at high risk of bias (red).
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and these diets were combined to one group as described
in the Cochrane Handbook [20]. Data extraction was
conducted independently by both authors, with disagree-
ments resolved by consensus.
Results
Literature search and characteristic of studies
A total of 15 studies extracted from 3862 articles met
the inclusion criteria and were analyzed in the system-
atic review [22-36]. The detailed steps of the meta-











Studies included in qualita
synthesis 
(n = 15)
Studies included in quantit
synthesis (meta-analysi
(n = 15) 
Figure 2 Flow diagram.in Figure 2. General study characteristics are given in
Table 1. In case of more than one LP/LF group within a
single study design, all LP interventions were combined
as recommended by the Cochrane Collaboration [20].
Type 2 diabetes mellitus (T2D) was not defined as an
exclusion criteria, and a total of three studies enrolling
subjects with T2D were included in the present meta-
analysis [24,32,33]. 13/15 studies reported the distribu-
tion of gender (1200 women vs. 690 men).
The pooled estimate of effect size for the effects of HP
as compared to LP on primary and secondary outcomes
are summarized in Table 2.onal records identified through 
other sources
(n =1) 
Records excluded: <18 years, <12  




Full-text articles excluded, with reasons
(n = 22)
HP/LF or LP/LF (>30% fat) (n=14) 
Comparison low calorie diet (n=1)
Slimfast soy based meal replacement (n=2)
Lupin enriched foods (n=2)
Duplicate data (n=4)tive 
ative 
s)
Table 1 General characteristics of randomized controlled intervention trials included in the meta-analysis








BMI (kg/m2), Female (%) Protein(%),
Carbohydrates(%),
Fat(%)% diabetics Male (%)
Brinkworth et al. 2004 I [23] 58 50.2 16 HP/LF vs. 30%, 40%, 30% 1555 (12 weeks), energy balance
(4 weeks), no restriction (follow up)
27% 2
34 77.5% LP/LF 15%, 55%, 30% 1555 (12 weeks), energy balance
(4 weeks), no restriction (follow up)
23%
0% 22.5%
Brinkworth et al. 2004 II [24] 66 >60 15 HP/LF vs. 30%, 40%, 30% 1600 (8 weeks) energy balance
(4 weeks), no restriction (follow up)
39% 3
27-40 n.d LP/LF 15%, 55%, 30% 1600 (8 weeks) energy balance
(4 weeks), no restriction (follow up)
42%
100% n.d
Clifton et al. 2007 [25] 79 49 15 HP/LF vs. 34%, 46%, 20% 1340 (12 weeks), energy balance
(follow up, 52 weeks)
29% 2
32.8 100% LP/LF 17%, 64%, 20% 1340 (12 weeks), energy balance
(follow up, 52 weeks)
38%
0% 0%
Dansinger et al. 2005 [26] 80 49 12 HP/LF vs. 30%, 40%, 30% no 35% 4
35 48% LP/LF 10-15%, >65%, 10% no 50%
n.d 52%
Das et al. 2007 [27] 34 35 12 HP/LF vs. 30%, 40%, 30% 1900 18% 2
27.6 n.d LP/LF 20%, 60%, 20% 1960 12%
0% n.d
Delbridge et al. 2009 [28] 141 44 12 HP/LF vs. 30%, 40%, 30% no 37% 3
39 50% LP/LF 15%, 55%, 30% no 41%
n.d 50%
Due et al. 2004[29] 50 39.6 12 HP/LF vs. 30%, 40%, 30% no 8% 1
30.4 76% LP/LF 15%, 55%, 30% no 28%
0% 24%
Gardner et al. 2007 [22] 232 40.6 12 HP/LF vs. 30%, 40%, 30% yes 23% 4
31.33 100% LP/LF* 10-15%, 55-70%, 10/30% no/yes 23%
0% 0%
Keogh et al. 2007 [31] 25 48.7 12 HP/LF vs. 40%, 33%, 27% 1435 n.d 1
32.9 68% LP/LF 20%, 60%, 20% 1435 n.d
0% 32%
Krebs et al. 2012 [32] 419 57.9 24 HP/LF vs. 30%, 40%, 30% −500 30% 4
36.6 60% LP/LF 15%, 55%, 30% −500 24%
100% 40%
Larsen et al. 2011 [33] 99 59.2 12 HP/LF vs. 30%, 40%, 30% 1530 (3 months), energy balance
(follow up)
19% 4




Layman et al. 2008 [30] 130 45.4 12 HP/LF vs. 30%, 40%, 30% 1700 women, 1900 men 36% 2
32.6 55% LP/LF 15%, 55%, 30% 1700 women, 1900 men 55%
n.d 45%
McAuley et al. 2006 [34] 48 n.d 12 HP/LF vs. 30%, 40%, 30% no 7% 2
n.d 100% LP/LF 15%, 55%, 30% no 25%
Insulin resistant 0%
Sacks et al. 2009 [35] 406 50.5 24 HP/LF vs. 25%, 55%, 20% −750 22% 4
33 64% LP/LF 15%, 65%, 20% −750 16%
0% 36%
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Table 1 General characteristics of randomized controlled intervention trials included in the meta-analysis (Continued)
Wycherley et al. 2012 [36] 123 20-65 12 HP/LF vs. 35%, 40%, 25% 1700 43% 4
27-40 0% LP/LF 17%, 58%, 25% 1700 44%
0% 100%
*two kind of LP/LF diets (very LF: 10% and LF: 30% of total energy content).
HP, high-protein; LF, low fat; LP, low-protein; n.d, no data.
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Weight/ Waist circumference/ Fat Mass
Weighted mean differences (WMD) in change of weight
[−0.39 kg (95% CI −1.43 to 0.65), p = 0.46], WC [−0.98 cm
(95% CI −3.32 to 1.37), p = 0.41] and FM [−0.59 kg (95%
CI - -1.32 to 0.13), p = 0.11] were not statistically signifi-
cant when comparing HP vs. LP dietary protocols.Serum lipids
No significant changes were observed for TC [WMD: -
2.51 mg/dl (95% CI −7.74 to 2.71), p = 0.35], LDL chol-
esterol [WMD: 1.58 mg/dl (95% CI -5.36 to 8.53),
p = 0.66], HDL cholesterol [WMD: 0.90 mg/dl (95%
CI −0.09 to 1.89), p = 0.08], and TG [WMD: -2.87 mg/dl
(95% CI −11.13 to 5.38), p = 0.49] between HP and
LP diets.Blood Pressure/CRP
When comparing HP and LP regimen, no significant
differences could be found with respect to WMDs
in change of CRP [0.22 mg/dl (95% CI −0.36 to 0.79),
p = 0.46] and blood pressure values [DBP: -0.42 mmHg
(95% CI −1.37 to 0.54), p = 0.39; and SBP: -1.61 mmHg
(95% CI −3.45 to 0.23), p = 0.09].Table 2 Pooled estimates of effect size (95% confidence inter
effects of HP vs. LP diets on cardiovascular and metabolic ris
Outcomes No. of studies Participants WM
Weight (kg) 13 971 −0.
WC (cm) 8 727 −0.
FM (kg) 10 913 −0.
TC (mg/dl) 12 1251 −2.
LDL-C (mg/dl) 13 1522 1.5
HDL-C (mg/dl) 14 1563 0.9
TG (mg/dl) 14 1563 −2.
DBP (mmHg) 11 1402 −0.
SBP (mmHg) 11 1414 −1.
CRP (mg/dl) 4 222 0.2
FG (mg/dl) 11 1357 −0.
FI (μIU/ml) 11 1086 −0.
HbA1c (%) 3 431 0.0
CI, confidence intervalls, CRP, high-sensitive-C reactive protein; DBP, diastolic blood
glycosylated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-d
TG, triacyglycerols; WC, waist circumference; WMD, weighted mean difference.Glycemic control
Decreases in FI were significantly more explicit in sub-
jects adhering to an HP diet as compared to those fol-
lowing an LP regimen [WMD: -0.71 μIU/ml (95%
CI −1.36 to −0.05), p = 0.03] (Figure 3). None-significant
changes were observed for FG [WMD: -0.63 mg/dl (95%
CI −1.93 to 0.67), p = 0.34], and HbA1c [WMD: 0.07%
(95% CI −0.17 to 0.31), p = 0.55].
Sensitivity analysis
Articles with a Jadad quality score ≥ 3 only were included
in the sensitivity analyses. A total of 8/15 studies remained
for sensitivity analyses [22,24,26,28,32,33,35,36]. The re-
sults of the primary analyses could be confirmed for all
the parameters that were not significantly altered in differ-
ent ways in the HP and LP groups. Furthermore, changes
in FI turned out to be of similar dimension as well when
studies with poor Jadad scores were excluded. In an add-
itional sensitivity analysis, studies enrolling patients with
T2D [33,34,36] were discarded to account for a potential
“reproducibility effect” on the pooled WMD when compar-
ing the results of the present systematic review with a
meta-analysis by Santesso et al. [7], where T2D represented
an exclusion criterium. Results were not significantly differ-
ent as compared to the comprehensive meta-analysesvals) expressed as weighted mean difference for the
k factors
D 95% CI p-values Inconsistency I2
39 [−1.43, 0.65] 0.46 0%
98 [−3.32, 1.37] 0.41 72%
59 [−1.32, 0.13] 0.11 0%
51 [−7.74, 2.71] 0.35 32%
8 [−5.36, 8.53] 0.66 79%
0 [−0.09, 1.89] 0.08 0%
87 [−11.13, 5.38] 0.49 21%
42 [−1.37, 0.54] 0.39 0%
61 [−3.45, 0.23] 0.09 41%
2 [−0.36, 0.79] 0.46 0%
63 [−1.93, 0.67] 0.34 0%
71 [−1.36, -0.05] 0.03 0%
7 [−0.17, 0.31] 0.55 0%
pressure; FG, fasting glucose; FI, fasting insulin; FM, fat mass; HbA1c,
ensity lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol,
Figure 3 Forest plot showing pooled WMD with 95% CI for fasting insulin (μIU/ml) for 10 randomized controlled high-protein diet
studies. For each high-protein study, the shaded square represents the point estimate of the intervention effect. The horizontal line joins the
lower and upper limits of the 95% CI of these effects. The area of the shaded square reflects the relative weight of the study in the respective
meta-analysis. The diamond at the bottom of the graph represents the pooled WMD with the 95% CI for the 10 study groups. Abbreviations:
HP = high-protein; LP = low-protein; I2 = Inconsistency.
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HDL-C was more pronounced in the HP as compared to
the LP diet [WMD: 1.50 mg/dl (95% CI 0.37 to 2.62), p =
0.009] (Figure 4).
Publication bias
The funnel plots (with respect to effect size changes for
Weight, WC, FM, TC, LDL-C, HDL-C, TG, CRP, DBP,
SBP, FG, FI and HbA1c in response to HP diets) indicates
little to moderate asymmetry, suggesting that publication
bias cannot be completely excluded as a factor of influence
on the present meta-analysis. It remains possible that small
studies yielding inconclusive data have not been published.
Heterogeneity
Considerable heterogeneity was found with respect to WC
(I2 = 72%) and LDL-C (I2 = 79%) in the primary analysis.
Moderate heterogeneity was observed for TC (I2 = 32%)
and SBP (I2 = 41%), the other outcomes showed low het-
erogeneity (I2 = 0-21%).Figure 4 Forest plot showing pooled WMD with 95% CI for HDL-chol
studies (excluding T2D subjects). For each high-protein study, the shade
horizontal line joins the lower and upper limits of the 95% CI of these effec
study in the respective meta-analysis. The diamond at the bottom of the g
groups. Abbreviations: HP = high-protein; LP = low-protein; I2 = InconsistencDiscussion
In this systematic review, HP dietary protocols were
compared with LP regimens with respect to their effects
on biomarkers of obesity and obesity-associated disor-
ders such as diabetes or cardiovascular disease. Analyses
were restricted on HP as well as LP diets providing ≤
30% of TEC in the form of fat to prevent potential bias
due to variations in total fat intake. Main findings sug-
gest no advantages or disadvantages of a higher dietary
protein content. None of the dietary protocols turned
out to be superior to its counterpart with regard to the
biomarkers under investigation. Following primary ana-
lysis, decreases in fasting insulin were significantly more
pronounced in HP diets. However, this was no longer
valid after inclusion of high quality trials only in the sec-
ondary analysis. The raise in HDL-C turned out to be
more pronounced in the HP group compared to the LP
group following sensitivity analysis excluding studies
that enrolled patients with T2D. In a previous study, HP
diets exerted a 12%-increase in HDL-C under closelyesterol (mg/dl) for 10 randomized controlled high-protein diet
d square represents the point estimate of the intervention effect. The
ts. The area of the shaded square reflects the relative weight of the
raph represents the pooled WMD with the 95% CI for the 10 study
y; T2D = type 2 diabetes.
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vide evidence that higher fat intake was associated with
higher levels of HDL-C when compared to low-fat diets
[38,39]. With respect to the studies included in the present
systematic review, the trials by Gardner et al. [22],
Dansinger et al. [26], and McAuley et al. [34] reported
higher intakes of total fat at the end of their 12 months
protocols (dietary records) in the HP groups as compared
to the respective LP counterparts. Omitting these trials to
the sensitivity analysis, changes in HDL-C turned out to
be similar in both HP and LP regimen (data not shown),
suggesting that HDL-C response was due to dietary fat
content rather than to protein consumption.
Taken together, these results are in discrepancy with a
recent meta-analysis by Santesso and co-workers [7] who
reported weight loss, WC, HDL-C, TG, SBP, DBP and FI
to be significantly more improved following short-and
long-term HP diets as compared to LP protocols. The dif-
ferent findings might at least in part be explained by the
fact that only long-term studies with a duration ≥ 12 months
were included in the present meta-analysis. In addition,
both post-intervention values as well as changes in mean
differences were used as suggested by the Cochrane
Collaboration [20] to avoid a standardized mean differ-
ences method, whereas Santesso et al. [7] separated be-
tween primary (change from baseline values) and secondary
(final values) analyses. These results indicate that HP diets
do not exert favorable effects on anthropometric measures
like body weight, fat mass and waist circumference.
However, in a meta-regression by Krieger et al. [11]
high-protein intake turned out to be a significant pre-
dictor of fat free mass retention, thereby compensating a
potential side-effect of long-term energy restriction.
Dietary protein content of the high-protein diets in-
cluded in this meta-analysis varied between 30-40% of
TEC, which is within the age-dependent AMDR of 5-35%
for all but one RCT [31]. Via analysis of the National
Health and Nutrition Examinations Survey conducted be-
tween 2003 and 2004, Fulgoni [5] concluded that the ac-
tual intake of protein in US-American adults of 1.3 g * kg
body weight-1 * d-1 exceeds the DRI values of 0.66 g * kg
body weight-1 * d-1. He suggested that recommendations
could be adapted to 25-30% of TEC, assuming benefits of
higher protein intake e.g. on regulation of body weight.
Regarding biomarkers such as weight, waist circumference
or fat mass, the present meta-analysis does not support
this concept.
Three RCTs included in this meta-analysis investigated
the effects of HP regimens on biomarkers of kidney
function in patients with T2D. In all trials, HP diets did
not affect renal functions assessed via measurement of
serum creatinine and microalbuminurea [32,33,36]. Like-
wise, a 2-year RCT by Friedman et al. [40] reported no
harmful effects of a high-protein/low carbohydrate dieton glomerular filtration rate, albuminuria, or fluid and
electrolyte balance. With respect to prospective cohort
studies, a systematic review by Mente et al. [41] indi-
cated no significant correlations between animal protein
sources, e.g. eggs, milk or meat on coronary heart dis-
ease (CHD), whereas vegetable protein sources like nuts
were associated with a decreased risk. Findings from
Greece, Sweden and the US noted an increased all-cause
mortality following a HP/low carbohydrate diet based on
animal sources in both women and men whereas a
vegetable-based low-carbohydrate diet was associated
with lower all-cause and cardiovascular disease mortality
rates [42-44].
This systematic review did not consider unpublished
data, and with respect to the moderate asymmetry of the
Funnel plots, it cannot be excluded that publication bias
such as lack of published studies with inconclusive results
may have at least a moderate impact on the effect size
estimates. An important limitation of dietary intervention
trials is the heterogeneity of various aspects and charac-
teristics of the study protocols. The literature chosen for
the present meta-analysis varies regarding type(s) of diets
used, definitions of HP and LP diets, study population (i.e.
BMI, type 2 diabetics, abnormal glucose metabolism),
intervention time, nutritional assessment as well as long-
term follow-ups (between 1 and 2 yrs.). In addition, some
studies were performed on hypocaloric terms, while others
provided an isocaloric diet.
Not all of the studies gave details on the quality of
their respective setup (e.g. method of randomization,
follow-up protocol with reasons for withdrawal) yielding
Jadad scores < 3. However, following sensitivity analyses
including high quality studies only (Jadad score ≥ 3),
pooled estimates of effect size were similar to those
obtained with the complete set of studies. Some compar-
isons within the present meta-analyses were done using
both post-intervention values and changes in mean dif-
ference, which is considered to be a legitimate procedure
as described by the Cochrane Collaboration [20], and
should not be regarded as a limitation.
In summary, the present meta-analysis investigated the
long-term effects of HP vs. LP both low in fat on bio-
markers predicting the outcome of obesity, cardiovascu-
lar disease and glycemic control. Since biomarkers under
investigation were not affected by changes in dietary
protein content, unanimous recommendation of a high-
protein dietary approach is not supported by evidence.
With respect to the potential risk of high-protein con-
tents, further studies are required before dietary recom-
mendations can be changed towards a higher percentage
of daily protein consumption.Competing interests
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